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Purpose: The goal of the Lifeline Endovascular Registry is to provide a minimal, yet comprehensive, data set of patient 
follow-up that can evaluate the long-term safety of endovascular g afts used in abdominal aortic aneurysm repair. 
Methods: Follow-up data have been collected on 1757 patients for this first report, including 1646 endovascular graft 
recipients and 111 surgical patients receiving treatment for abdominal aortic aneurysm. 
Results: Logistic regression of 1-year survival indicates that the factors most likely to decrease 1-year survival for the 
surgical group are renal failure and larger aneurysm size. For the endovascular g aft recipients, the presence of renal 
failure, chronic obstructive pulmonary disease, congestive heart failure, larger aneurysm size, and increased age demon- 
strates a decrease in 1-year survival. Approximately 80% (1309) of the endovascular recipients have been followed for 
1 year. Of these 1309 patients, 17% (222) have incurred an endoleak, and enlargement of the aneurysm has occurred 
in 4.6% (60). There was a total of 80 (4.9%) endovascular graft recipients converted to surgery. The most prevalent fac- 
tors causing conversion to surgery were an increase in aneurysm diameter, aneurysm rupture, and the presence of a 
proximal endoleak. 
Conclusions: Although the data collected by the Registry thus far are limited, we anticipate rapid expansion of the 
Registry to include data from other manufacturers and investigators. Nevertheless, early data analysis does demonstrate 
the importance of surveillance of endovascular g aft recipients. Through the collection and analysis of Registry data, 
adverse vents continue to be captured, enabling the monitoring of long-term safety of endovascular g afts and the eval- 
uation of graft performance. Data on comorbidities and postoperative factors, collected and evaluated for their effect 
on survival of the graft recipients, also provide information on optimal patient selection and management. We expect 
that the next report will support and expand on these findings, providing continuing evidence of the value of a national 
endovascular registry. (J Vase Surg 2002;35:616-20.) 
The Lifeline Registry of Endovascular Aneurysm 
Repair has the goal of collecting long-term data on patients 
receiving endovascular grafts (EGs) and surgical patients. 
These data will be used to evaluate the aggregate safety and 
effectiveness of EGs in treating aneurysmal disease. This is 
the first data report from the Registry. The information 
presented herein represents data on two EG devices. 
PREL IMINARY RESULTS 
Demographic  data. Follow-up data have been col- 
lected on 1757 patients that were treated for an abdomi- 
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nal aortic aneurysm. There are 1646 EG recipients regis- 
tered from 40 clinical centers and 111 surgical patients 
from 18 centers (Fig 1, Table I). Whites comprise the 
overwhelming majority of the EG group (92.3%; 1519) 
and the surgical group (97.3%; 108). The majority of the 
patients receiving a graft (88.6%) or surgery (76.6%) were 
male (Table II). The mean age for graft recipients was 
73.1 years, whereas the mean age fbr surgical patients was 
71.1 years (Fig 2). The most prevalent risk factors in this 
patient population are hypertension, myocardial infarc- 
tion, and chronic obstructive pulmonary disease (COPD). 
Both groups have similar baseline risk factors; however, 
EG recipients have significantly less hypertension than the 
surgical group (Table III). 
Procedure data. The majority of the aneurysms 
(85.7%) are between 40 and 70 mm, with nearly 50% in 
the range 50 to 59 mm. Both groups have a similar distri- 
but ion of aneurysm diameter. The significantly fewer 
patients with aneurysms in the 50 to 59 mm range in the 
surgical group may be a chance result in a multitesting 
environment. The mean aneurysm size for the surgical 
group is 55.1 mm, and for EG recipients, it is 55.7 mm 
(Table IV). 
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Fig 1. Patient distribution among sites. EG recipients make up the majority of patients in the Registry, 
even at sites with surgical patients. 
Table I. Patient distribution among sites Table I I .  Gender distribution* 
Clinical centers EG 
EG (40 centers) Surgery (18 ct'.nters) 
Mean 41.2 patients 6.2 patients 
Median 25.5 patients 5.5 patients 
Table I I I .  Basclinc risk factors 
SuEAical 
Ge**der n % ~ % 
Female 187 11.4 26 23.4 
Male 1459 88.6 85 76.6 
Total 1646 100 111 100 
*Both groups are predominantly male. However, the surgical group 
includes ignificantly more women than the EG group (P < .0001). 
EG &~rgery 
Risk factor n % n % P value 
Myocardial infarction 613 37.2 43 38.7 .762 
Hypertension 1051 63.9 79 71.2 .004 
Diabetes 188 l1.4 11 9.9 .757 
Renal insufficiency 65 4.0 5 4.5 .8 
COPD 483 29.3 33 29.7 .915 
CHF 183 11.1 8 7.2 .268 
Three noticeable causes of  conversion to open surgery, 
aside from implant failure, are an increase in aneurysm 
diameter, rupture of the aneurysm, or a proximal endoleak 
from the endovascular graft (Table V), 
Adverse event data. Adverse events were tracked at 
immediate postprocedure, discharge, 3 months postproce- 
dure, 6 months postprocedure, and annually for 5 years. A 
total of  1646 EG patients have participated in the Lifeline 
Registry. Table VI shows the number of  patients that have 
been seen tbr each data collection point. At most of  the 
visits, endolcaks were observed in at least 20% of the graft 
recipients. 
The percentage of deaths for graft recipients (14.9%) 
is similar to the percentage of deaths in the surgical group 
(12.6%). However,  the cause of  death varies between 
groups. Deaths in the graft populat ion were primarily 
caused bycardiopulmonary arrest, myocardial infarction, 
cancer, and other, unknown causes. In contrast, deaths in 
the surgical group were primarily caused by pneumonia 
and cardiac arrest (Table VII). 
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Fig 2. A, Surgical group age distribution (n = 111; mean age, 71.1 y; SD, 7.09). B, EG group age distribu- 
tion (n = 1644; mean age, 73.1 y; SD, 7.91 ). The mean age of the patient population was 72.9 years. A two- 
tailed t test showed that the surgical group was significantly younger (P = .008). 
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Fig 3. Survival tbr United States population and the surgery and EG groups. No statistically significant dif- 
ference can be dctcrmincd between the EG and surgery groups because of the small numbcr of surgical patients 
available tbr analysis. 
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Fig 4. Eftkct of renal failure, COPD, and CHF on survival of  EG recipients. Survival analysis of graft recipi- 
ents demonstrates that patients without comorbidities have a greater chance tbr survival than do patients with 
COPD, renal failure, or CHF. 
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Fig 5. Effect of aneurysm size on survival for EG group. The probability of graft recipient survival is 
inversely proportional to aneurysm diameter. As aneurysm diameter increases, the probability that a graft 
recipient survives decreases. 
Tab le  IV. Aneurysm diameter distr ibution at baseline 
EG Surgery 
Size n % n % P value 
Unknown 21 1.3 8 7.2 
<40 mm 40 2.4 3 2.7 
40-49mm 329 20.0 28 25.2 
50-59mm 776 47.1 42 37.8 
60-69mm 309 18.8 21 18.9 
70-79 mm 124 7.5 6 5.4 
~80 mm 47 2.9 3 2.7 
Total 1646 100 111 100 .5773 
Table  V. Surgical conversion cause and rate* 
Cause n % of all conversions 
Aneurysm diameter increase 8 10.0 
Aneurysm rupture 11 13.8 
Proximal endoleak 9 11.3 
Distal endoleak 1 1.3 
Left iliac endoleak 1 1.3 
IM branch endoleak 1 1.3 
Lumbar branch endoleak 2 2.5 
Modular disconnection endoleak 1 1.3 
Endoleak source unknown 6 7.5 
Migration 5 6.3 
Loss of device integrity 2 2.5 
Implant failure 44 55.0 
Unknown 4 5.0 
*This table is not mutually exclusive. Patients with multiple causes for con 
version are listed more than once. 
Total number of patients converted is 80. 
IM, Infkrior mesenteric. 
SURVIVAL  ANALYS IS  
Logistic regression of  1-year survival indicates that the 
factors most likely to decrease 1-year survival for the sur- 
gical group are the presence of  renal failure and larger 
aneurysm size. However, for the EG group, the factors are 
the presence of  renal failure, COPD,  congestive heart fail- 
ure (CHF),  larger aneurysm size, and increased age. Using 
Cox proport ional  hazards models, the resulting survival 
curves are given in Figs 3, 4, and 5. 
CONCLUSION 
Early data analysis demonstrates  the importance of  
survei l lance of  EG recipients. Through the col lect ion 
and analysis of  Registry data, adverse events were cap- 
tured,  enabl ing the mon i to r ing  of  long- term safety of  
EGs and  the eva luat ion  of  graft  per fo rmance .  Fur-  
thermore ,  data on comorbid i t ies  and postoperat ive fac- 
tors were col lected and  evaluated for the i r  effect on  
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Tab le  V I .  Adverse events o f  EG patients by t imepoint  
Postprocedure Discharge 3 months 6 months 12 months 24 months 36 months 48 months 60 months 
Event  n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Endoleak 407 (24.7) 4551 (28.4) 90 (20.4) 327 (23.3) 222 (17) 198 (21.4) 61 (14.7) 16 (20.8) 1 (100) 
Rupture 0 (0) 3 (0.2) 0 (0) 0 (0) 1 (0.1) 7 (0.8) 1 (0.2) 0 (0) 0 (0) 
Enlarged N/A  73 (4.6) 12 (2.7) 67 (4.8) 60 (4.6) 61 (6.6) 36 (8.7) 7 (9) 0 
aneurysnl 
Prosthesis 1 (0.1) 9 (0.6) 2 (0.4) 11 (0.8) 2 (0.2) 48(55.2) 30 (7.2) 7 (9) 1 (100) 
migration 
Loss of device N /A  0 0 3 (0.2) 3 (0.2) 8 (0.9) 7 (1.7) 0 0 
integrity 
Obstruction 55 (0.3) 13 (0.8) 2 (0.4) 7 (0.55) 9 (0.7) 4 (0.4) 1 (0.2) 3 (3.9) 0 
Change in 155 (1) 10 (0.6) 55 (1.i) 1 (0.1) 6 (0.55) 55 (0.55) 3 (0.7) 0 0 
graft alignment 
Total patients 1646 (100) 15589 (96.55) 441 (6.8) 1403 (855.2) 1309 (79.55) 926 (556.2) 4155 (255.2) 77 (46.8) 1 (0.1) 
seen at this time 
Tab le  V I I .  Pr imary causes o f  death 
EG Surgery 
Ca use n % n % 
AAA rupture 4 1.6 1 7.1 5 
Cardiopulmonary arrest 29 1 1.8 0 0 
Cardiac arrest 12 4.9 2 14.3 
Myocardial infarction 26 10.6 1 7.I5 
Respiratory failure 20 8.2 1 7.1 5 
Cardiac, other 1 2 4.9 0 0 
CHF 12 4.9 1 7.15 
COPD ,5 2.0 0 0 
Pneumonia 1 1 4.5 3 2 1.4 
Pulmonary, other 3 1.2 0 0 
Cerebrovascular ccident 1 0 4.1 0 0 
Renal failure 6 2.4 0 0 
Cancer 36 1 4.7 3 2 1.4 
Sepsis 5 2.0 0 0 
TAA rupture 4 1.6 0 0 
Other* 11 4.5 2 14.3 
Unknown 39 15.9 0 0 
Total 245t 100 14; t 100 
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm. 
* Other includes anoxic encephalopathy, mtraabdominal hemorrhage, hepatic fhilurc (2), amyotrophic lateral sclerosis complications, dementia, ischemic col- 
litis, bowel obstruction, gastrointestinal bleeding (2), diabetes mcllitus. 
t14.9% of EG recipients. 
*12.6% of the surgical population. 
survival o f  the  graft  rec ip ients .  A l though the surgical  
data co l lected by the  Regist ry  thus  far are l imited,  addi-  
t ional  data f rom other  manufacturers  will facil itate more  
in format ive compar i sons  wi th  the graft  exper ience.  We 
expect  that  the  next  repor t ,  w i th  cons iderab ly  more  
data, will suppor t  and expand these f indings and pro-  
vide cont inu ing  ev idence  o f  the  value o f  a nat iona l  
endovascu lar  registry. 
